(2 ' -deoxy-ribofuranosyl) -1,3,4, 7-tetrahydro- (1,3) iazepin-2-0ne derivatives for treating cancer

Details for Australian Patent Application No. 2010234637 (hide)

Owner Eisai Inc.

Inventors Belyakov, Sergei; Duvall, Bridget; Ferraris, Dana; Hamilton, Gregory; Vaal, Mark

Agent Fisher Adams Kelly

Pub. Number AU-A-2010234637

PCT Pub. Number WO2010/118006

Priority 61/167,112 06.04.09 US

Filing date 6 April 2010

Wipo publication date 14 October 2010

International Classifications

C07H 19/04 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/7052 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/118006 Priority application(s): WO2010/118006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234639-Devices for injection of gaseous streams into a bed of fluidized solids

2010234632-Accumulating apparatus for discrete paper or film objects and related methods